Opyl Ltd (OPL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Opyl Ltd (OPL) has a cash flow conversion efficiency ratio of 1.994x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-619.98K ≈ $-438.67K USD) by net assets (AU$-310.99K ≈ $-220.05K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Opyl Ltd - Cash Flow Conversion Efficiency Trend (1996–2024)
This chart illustrates how Opyl Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read OPL current and long-term liabilities for a breakdown of total debt and financial obligations.
Opyl Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Opyl Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RPM Automotive Group Ltd
AU:RPM
|
0.023x |
|
Ashoka India Equity Investment Trust PLC
LSE:AIE
|
-0.013x |
|
PEPTONIC MEDICAL
F:28L
|
N/A |
|
Sawang Export Public Company Limited
BK:SAWANG
|
-0.029x |
|
STRATHMORE PLUS URANIUM
F:TO3
|
N/A |
|
Kingsland Minerals Ltd
AU:KNG
|
-0.047x |
|
Sonetel AB
ST:SONE
|
0.069x |
|
Lottery.com Inc.
NASDAQ:SEGG
|
-0.194x |
Annual Cash Flow Conversion Efficiency for Opyl Ltd (1996–2024)
The table below shows the annual cash flow conversion efficiency of Opyl Ltd from 1996 to 2024. For the full company profile with market capitalisation and key ratios, see Opyl Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | AU$-90.16K ≈ $-63.79K |
AU$-2.06 Million ≈ $-1.46 Million |
22.811x | +574.80% |
| 2023-06-30 | AU$-403.59K ≈ $-285.56K |
AU$-1.36 Million ≈ $-965.34K |
3.380x | +159.40% |
| 2022-06-30 | AU$267.01K ≈ $188.93K |
AU$-1.52 Million ≈ $-1.08 Million |
-5.691x | -1277.78% |
| 2021-06-30 | AU$2.19 Million ≈ $1.55 Million |
AU$-903.65K ≈ $-639.39K |
-0.413x | +71.13% |
| 2020-06-30 | AU$719.18K ≈ $508.86K |
AU$-1.03 Million ≈ $-728.08K |
-1.431x | -127.41% |
| 2019-06-30 | AU$-402.81K ≈ $-285.01K |
AU$-2.10 Million ≈ $-1.49 Million |
5.221x | +354.11% |
| 2018-06-30 | AU$1.39 Million ≈ $986.43K |
AU$-2.86 Million ≈ $-2.03 Million |
-2.054x | +83.53% |
| 2017-06-30 | AU$230.83K ≈ $163.32K |
AU$-2.88 Million ≈ $-2.04 Million |
-12.471x | -787.81% |
| 2016-06-30 | AU$2.22 Million ≈ $1.57 Million |
AU$-3.12 Million ≈ $-2.20 Million |
-1.405x | -377.56% |
| 2015-06-30 | AU$1.33 Million ≈ $937.83K |
AU$-389.85K ≈ $-275.85K |
-0.294x | -2234.34% |
| 2014-06-30 | AU$5.77 Million ≈ $4.09 Million |
AU$-72.76K ≈ $-51.48K |
-0.013x | +58.48% |
| 2013-06-30 | AU$8.31 Million ≈ $5.88 Million |
AU$-252.29K ≈ $-178.51K |
-0.030x | -110.59% |
| 2012-06-30 | AU$10.12 Million ≈ $7.16 Million |
AU$-145.87K ≈ $-103.21K |
-0.014x | +40.22% |
| 2011-06-30 | AU$14.17 Million ≈ $10.02 Million |
AU$-341.50K ≈ $-241.63K |
-0.024x | +96.37% |
| 2010-06-30 | AU$1.69 Million ≈ $1.19 Million |
AU$-1.12 Million ≈ $-793.50K |
-0.664x | -182.04% |
| 2009-06-30 | AU$-4.04 Million ≈ $-2.86 Million |
AU$-3.27 Million ≈ $-2.31 Million |
0.810x | +4568.99% |
| 2008-06-30 | AU$69.38 Million ≈ $49.09 Million |
AU$-1.26 Million ≈ $-889.41K |
-0.018x | +57.21% |
| 2007-06-30 | AU$59.61 Million ≈ $42.18 Million |
AU$-2.52 Million ≈ $-1.79 Million |
-0.042x | -41.86% |
| 2006-06-30 | AU$52.13 Million ≈ $36.89 Million |
AU$-1.56 Million ≈ $-1.10 Million |
-0.030x | +70.01% |
| 2005-06-30 | AU$13.41 Million ≈ $9.49 Million |
AU$-1.33 Million ≈ $-944.26K |
-0.100x | -367.82% |
| 2004-06-30 | AU$16.09 Million ≈ $11.38 Million |
AU$-342.24K ≈ $-242.16K |
-0.021x | +41.20% |
| 2003-06-30 | AU$10.47 Million ≈ $7.41 Million |
AU$-378.80K ≈ $-268.03K |
-0.036x | -20.83% |
| 2002-06-30 | AU$9.85 Million ≈ $6.97 Million |
AU$-294.88K ≈ $-208.64K |
-0.030x | +44.96% |
| 2001-06-30 | AU$8.89 Million ≈ $6.29 Million |
AU$-483.84K ≈ $-342.34K |
-0.054x | +36.89% |
| 2000-06-30 | AU$9.41 Million ≈ $6.66 Million |
AU$-811.63K ≈ $-574.28K |
-0.086x | -99.74% |
| 1999-06-30 | AU$6.41 Million ≈ $4.53 Million |
AU$-276.48K ≈ $-195.63K |
-0.043x | +7.67% |
| 1998-06-30 | AU$6.42 Million ≈ $4.54 Million |
AU$-299.97K ≈ $-212.25K |
-0.047x | +41.37% |
| 1997-06-30 | AU$6.21 Million ≈ $4.39 Million |
AU$-495.03K ≈ $-350.27K |
-0.080x | +53.83% |
| 1996-06-30 | AU$6.15 Million ≈ $4.35 Million |
AU$-1.06 Million ≈ $-751.81K |
-0.173x | -- |
About Opyl Ltd
Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool strea… Read more